- AAM Biotechnology Opps 2023-2 F RE (USD) (Dist) (US00790D1708)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Alle auswählen Alle zurücksetzen

Speichern Schließen

(%)

US00790D1708

ISIN

Investmentfonds (MF)

Fondstyp

Advisors Asset Management

Anbieter

12,86 USD

NAV pro Aktie | 06/10/2025

06/10/2023

Startdatum

Ausschüttung von Dividenden

CIMJLU

CFI

Ticker

Formed

Status

Equity

Investitionsobjekt

Healthcare

Sektor

USA

Geographie

Physical

Replikationsmethode

Nein

UCITS

Letzte Daten zum

Letzte Daten zum 06/10/2025

Zum Vergleichen hinzufügen

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

80 234

Aktien

167 970

ETF & Funds

80 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

Bond-Screener
Watchlist
Excel-Add-In

Zugang erhalten

Kurs-Dynamik

Fund profile

The AAM Biotechnology Opps 2023-2 seeks capital preservation and appreciation by investing in a portfolio comprised primarily of U.S. healthcare companies

profile

The AAM Biotechnology Opps 2023-2 F RE (USD) (Dist) is a(n) Equity Mutual Funds (MF) seeks to invest in Healthcare sector located in USA. The Advisors Asset Management fund’s base currency is USD and the share class was registered 06.10.2023 with unique ISIN - US00790D1708. The AAM Biotechnology Opps 2023-2 F RE (USD) (Dist) pays dividends 0 time(s) per year.

Andere Aktien dieses Fonds

AAM Biotechnology Opps 2023-2 CA (USD) (Dist)

AAM Biotechnology Opps 2023-2 F CA (USD) (Dist)

AAM Biotechnology Opps 2023-2 RE (USD) (Dist)

Alle anzeigen

- AAM Biotechnology Opps 2023-2 F RE (USD) (Dist) (US00790D1708)

Kurs-Dynamik

Fund profile

profile

Einkommens-Zahlung (US00790D1708)

Andere Aktien dieses Fonds

Andere ETFs und Fonds dieses Anbieters

Ähnliche Etf & Fonds